Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 436 results found. Search for [ Serum Institute of India vaccine trials ]

Results 60 to 80 of 436
PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


BusinessToday.In
March 3, 2021
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


BusinessToday.In
March 3, 2021
Data from 25,800 participants who received a vaccine or placebo in 1:1 ratio showed that the vaccine was well-tolerated; Bharat Biotech said the trial conducted with ICMR was the largest in India


BusinessToday.In
March 2, 2021
As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


Joe C Mathew
February 19, 2021
Coronavirus vaccine: The Covid-19 vaccine candidate of Novavax is being studied in two ongoing pivotal Phase 3 clinical trials: in the United States and Mexico, as well as in the United Kingdom


BusinessToday.In
February 19, 2021
In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks


Reuters
January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts


BusinessToday.In
January 30, 2021
Serum Institute of India CEO Adar Poonawalla said the company's tie-up with American vaccine developer Novavax has published 'excellent efficacy results'


BusinessToday.In
January 30, 2021
Coronavirus vaccine: J&J plans to seek emergency use authorisation from the US Food and Drug Administration next week. It has said it plans to deliver 1 billion doses in 2021 and will produce the vaccine in the United States, Europe, South Africa and India


BusinessToday.In
January 30, 2021
Sputnik V is undergoing Phase-3 trials in India currently which is expected to be completed by February


BusinessToday.In
January 29, 2021
The vaccine wastage can be largely attributed to not enough volunteers turning up after the vaccine vials were opened, which need to be utilised in up to four hours


Reuters
January 29, 2021
Serum expected a decision on an Indian trial of Novavax's vaccine soon, Chief Executive Adar Poonawalla said, hours after the US company reported the efficacy data


PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation


BusinessToday.In
January 25, 2021
As per the government's norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India


PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet


Reuters
January 22, 2021
Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small


Reuters
January 21, 2021
If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use


BusinessToday.In
January 20, 2021
Bharat Biotech is developing the intranasal vaccine in partnership with the Washington University School of Medicine and US-based vaccine maker Ocugen


PAGES 4 OF 22  12345